Pulmonary Embolism Drugs Segmentation
Drug Class (Thrombolytics, Thrombosis, Heparins, Thrombin Inhibitors)
The thrombosis segment is estimated to gain largest market share by 2037. Thrombosis is a medical condition that is mainly caused by a lump of thick blood clots that forms in a blood vessel in the heart. Venous thrombosis is observed to be quite prevalent across the globe which is estimated to hike the market revenue. For instance, it was expected that every year, in every 1000, 1 of them suffer from venous thrombosis. The occurrence rate of thrombosis rises after the age of 45 and is quite higher in men than women. The risk factors of thrombosis include immobility, hospitalization, trauma, pregnancy, and others.
Distribution Channel (Hospital Pharmacy, Drug Store, Online Pharmacy)
The hospital pharmacies segment is predicted to account for significant market share by 2037. Hospitals are noticed to have luxury medical services in a single place. A huge staff of medical professionals is available to provide healthcare services 24/7. Furthermore, every nation is observed to spend a significant amount of money to develop hospital infrastructures to provide better medical services. The growth in the number of hospitals across the globe is anticipated to be backed by increasing income, population demographics, growing health awareness, and others.
Our in-depth analysis of the global market includes the following segments:
|
By Drug Class |
|
|
By Distribution Channel |
|
